Pharma Watch

Leading Pharma
Vifor Pharma PIVOTAL Trial Update

Vifor Pharma PIVOTAL Trial Update

Vifor Pharma’s PIVOTAL trial was the first trial, according to the commercial sponsor, to assess the optimal dosing
Kalvista Pharmaceuticals Update

Kalvista Pharmaceuticals Update

As reported in Citizen Tribune, KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical ...
Challenged Pharma
No results found.

Popular Posts

No results found.

24/7 News Feed

No results found.

Pin It on Pinterest